Hims & Hers shares plunge 28% on concerns over weight loss business, margins
Read more at CNBC
Topics
-
Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs
Hims & Hers Health reported fourth-quarter results on Monday that beat analysts' expectations, but the stock sank in extended trading.CNBC - 20h -
Nicolas Cage's ex is suing him and their son. She says Weston Cage beat her and dad shares blame
Nicolas Cage's attorney dismisses the allegations made by Christina Fulton, who's suing Weston Cage for assault and Nicolas for failing to prevent their son from committing acts of violence.Los Angeles Times - 5d -
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortageCNBC - 3d -
Novo Nordisk shares are rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.
Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer.MarketWatch - 7h -
Consumer confidence plunged in February amid rising economic concerns
Sharp drop in closely watched consumer sentiment gauge marks the biggest monthly decline in confidence in more than four years.CBS News - 3h -
Shares in Australia’s largest listed tech group plunge as majority of board quits
Allies of scandal-hit co-founder Richard White take control as independent directors resign over ‘intractable differences’Financial Times - 1d -
Novo’s Weight Loss Drugs Removed from FDA Shortage List
The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list.Inc. - 3d -
Love, loss and duty: Photojournalists share stories of war
Moving accounts of some of the men and women behind the striking images that have encapsulated the war.BBC News - 1d -
Block shares plunge 18%, for worst day on market in 5 years after earnings miss
Block had its worst day on the stock market since 2020 after the company reported an earnings miss.CNBC - 3d
More from CNBC
-
Apple shareholders reject outside proposal to end DEI programs
The rejection signals that investors still see value in Apple's diversity programs.CNBC - 10m -
Perplexity AI launching $50 million venture fund to back early-stage startups
Perplexity AI is getting ready to launch a $50 million fund focused on pre-seed and seed artificial intelligence startups in the U.S., CNBC has learned.CNBC - 1h -
Nvidia to report earnings amid infrastructure spending, DeepSeek concerns
Nvidia reports fourth-quarter financial results on Wednesday after the bell.CNBC - 4h -
Palisades nuclear plant signs agreement to build first of its kind small modular reactors in Michigan
Holtec International is trying to restart the Palisades nuclear plant and expand it with two small modular reactors through an agreement with Hyundai E&C.CNBC - 51m -
Healthy Returns: HHS Secretary RFK Jr. is making early moves that may affect vaccine access
Robert F. Kennedy Jr. is making moves that could affect immunization uptake and policy in the U.S., while Oracle submits a formal application to join TEFCA.CNBC - 1h
More in Business
-
Apple shareholders reject outside proposal to end DEI programs
The rejection signals that investors still see value in Apple's diversity programs.CNBC - 10m -
The Price of Shrimp Cocktail
A lot of people do.The New York Times - 19m -
Infusing Personality Into Your Brand
Piera Gelardi and Yelitsa Jean-Charles discuss how to create a unique brand identity through experimentation and strategic feedback loopsInc. - 20m -
VC Firm Slow Ventures Is Investing $60 Million in Content Creators. Here’s What It’s Looking For
Megan Lightcap, partner at Slow Creator, on the fund’s thesis and what makes a pitch successful.Inc. - 23m -
We're trimming our position in a recent standout stock in case the market changes its tune
The stock has benefited from Wall Street's defensive rotation into health care.CNBC - 31m